Skip to content

Inhibikase Therapeutics, Inc.: filings

Every Inhibikase Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 22 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 202632930001193125-26-344707
10-Q2026-05-12fiscal Q1 202632670001193125-26-219641
10-K2026-03-26fiscal FY 202536750001193125-26-126371
10-Q2025-11-14fiscal Q3 2025341020001193125-25-283169
10-Q2025-08-14fiscal Q2 202534950001193125-25-180899
10-Q2025-05-14fiscal Q1 202534720000950170-25-071635
10-K2025-03-27fiscal FY 202436740000950170-25-046096
10-Q2024-11-14fiscal Q3 202436900000950170-24-126766
10-Q2024-08-14fiscal Q2 202436860000950170-24-097022
10-Q2024-05-15fiscal Q1 202434720000950170-24-060579
10-K2024-03-27fiscal FY 202338760000950170-24-037160
10-Q2023-11-14fiscal Q3 2023371090000950170-23-063713
10-Q2023-08-14fiscal Q2 2023371050000950170-23-042389
10-Q2023-05-15fiscal Q1 202335740000950170-23-021974
10-K2023-03-31fiscal FY 202236720000950170-23-011133
10-Q2022-11-14fiscal Q3 2022371020000950170-22-025011
10-Q2022-08-12fiscal Q2 202231880000950170-22-017140
10-Q2022-05-16fiscal Q1 202222480000950170-22-010085
10-K2022-03-31fiscal FY 202126530000950170-22-005203
10-Q2021-11-15fiscal Q3 202126750000950170-21-004620
10-Q2021-08-16fiscal Q2 202126700001564590-21-044637
10-Q2021-05-17fiscal Q1 202127550001564590-21-028436

Inspect the source

Entity
Inhibikase Therapeutics, Inc. / CIK 0001750149
Captured
2026-09-21T17:25:56.509Z
SEC response SHA-256
203698bfa89561c7804b33011fdebdf3b28ff82ca1d2a96ec2c0a9014e52024e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001750149.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))